PRL and breast cancer: To date, only four GEMMs have been reported to develop HR+ mammary tumors: the Stat1-knockout [55], BLG-Cre; Kras(G12V) [56], NRL-PRL [57], and Wap-Cre; Pik3ca(H1047R) [58] models.